Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01086215 · ClinicalTrials.gov registry record
Registry of AngioJet Use in the Peripheral Vascular System
A clinical trial of Peripheral Vascular Disease and Venous Thrombosis, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 500
- Enrollment target
- 20
- Study locations
NCT01086215 is a study of Peripheral Vascular Disease and Venous Thrombosis that has completed, run by Boston Scientific Corporation. The registered enrollment target is 500 participants, above the 262-participant average among 25 other Peripheral Vascular Disease trials with a reported enrollment target (91% higher). The trial reports 20 study locations across 12 states.
The verdict
NCT01086215, a study of Peripheral Vascular Disease and Venous Thrombosis, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 20
- Study locations
Study Summary
The Registry involves the collection of information for research and educational purposes only on the use of AngioJet in the peripheral vascular system.
Conditions Studied
Study Locations (20)
Florida
- University of Florida- College of Medicine - Jacksonville
- First Coast Cardiovascular Institute - Jacksonville
- Sacred Heart Hospital - Pensacola
Louisiana
- Cardiovascular Consultants - Bossier City
- Terrebonne General Medical Center - Houma
- Regional Medical Center of Acadiana - Lafayette
Ohio
- Cleveland Clinic - Cleveland
- Grant Medical Center - Columbus
- Good Samaritan Hospital - Dayton
Arizona
- Phoenix Heart, PLLC - Glendale
- John C. Lincoln Deer Valley Hospital - Phoenix
North Carolina
- Duke University Medical Center - Durham
- Forsyth Medical Center - Winston-Salem
California
- Good Samaritan Hospital - Los Angeles
Delaware
- Christiana Care Health System - Newark
Georgia
- Chris Recknor PC - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01086215
The ClinicalTrials.gov registry entry for NCT01086215 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 262-participant average among 25 other Peripheral Vascular Disease trials with a reported enrollment target (91% higher). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Peripheral Vascular Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01086215 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, Louisiana, Ohio.
Frequently Asked Questions
What is clinical trial NCT01086215 about?
NCT01086215 is a clinical study titled "Registry of AngioJet Use in the Peripheral Vascular System". The Registry involves the collection of information for research and educational purposes only on the use of AngioJet in the peripheral vascular system.
What is the current status of trial NCT01086215?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2010-01. Estimated completion is 2013-09.
What conditions does trial NCT01086215 study?
This clinical trial studies the following conditions: Peripheral Vascular Disease, Venous Thrombosis, Embolism and Thrombosis.
Who is sponsoring clinical trial NCT01086215?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01086215 being conducted?
This trial has 20 study locations across Arizona, California, Delaware, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Vascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Mobility After Revascularization in Peripheral Artery Disease
RECRUITING · Phase 3
-
Far Red Light to Improve Functioning in PAD
RECRUITING · NA
-
Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease
RECRUITING · NA
-
ENhancing Exercise with LIGHT to Improve Functioning in PAD
RECRUITING · NA
-
BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
ACTIVE NOT RECRUITING · Phase 1
-
RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.